Search

Search Constraints

You searched for: Author/Creator Anand, I

Search Results

2. Additive prognostic value of cardiac biomarkers in patients with chronic obstructive pulmonary disease and heart failure. (14th October 2021)

4. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. Issue 1 (January 2022)